However, a study of ovarian cancer suggested that ERH may be a associated with a poor prognosis, and inhibiting ERH expression can promote cancer cell apoptosis and inhibit the metastasis and invasion of ovarian cancer cells by regulating the epithelial-mesenchymal transition (EMT) (Zhang et al., 2020). Here, ERH is linked to ovarian carcinoma.